Your browser doesn't support javascript.
loading
Concepts for the development of person-centred, digitally-enabled, Artificial Intelligence-assisted ARIA care pathways (ARIA 2024).
Bousquet, Jean; Schünemann, Holger J; Sousa-Pinto, Bernardo; Zuberbier, Torsten; Togias, Alkis; Samolinski, Boleslaw; Bedbrook, Anna; Czarlewski, Wienczyslawa; Hofmann-Apitius, Martin; Litynska, Justyna; Vieira, Rafael J; Anto, Josep M; Fonseca, Joao A; Brozek, Jan; Bognanni, Antonio; Brussino, Luisa; Canonica, G Walter; Cherrez-Ojeda, Ivan; Cruz, Alvaro A; Vecillas, Leticia de Las; Dykewicz, Mark; Gemicioglu, Bilun; Giovannini, Mattia; Haahtela, Tari; Jacobs, Marc; Jacomelli, Cristina; Klimek, Ludger; Kvedariene, Violeta; Larenas-Linnemann, Desiree E; Louis, Gilles; Lourenço, Olga; Leemann, Lucas; Morais-Almeida, Mario; Neves, Ana Luisa; Nadeau, Kari C; Nowak, Artur; Palamarchuk, Yuliia; Palkonen, Susanna; Papadopoulos, Nikolaos G; Parmelli, Elena; Pereira, Ana Margarida; Pfaar, Oliver; Regateiro, Frederico S; Savouré, Marine; Taborda-Barata, Luis; Toppila-Salmi, Sanna K; Torres, Maria J; Valiulis, Arunas; Ventura, Maria Teresa; Williams, Sian.
Afiliación
  • Bousquet J; Institute of Allergology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Immunology and Allergology, Berlin, Germany; ARIA, Montpellier, Fra
  • Schünemann HJ; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Immunology and Allergology, Berlin, Germany; Department of Health Research Methods, Evidence, and Impact & Department of Medicine, McMaster University, Hamilton, ON, Canada; Humanitas University, Pieve Emanuele, Milan, Italy.
  • Sousa-Pinto B; MEDCIDS - Department of Community Medicine, Information and Health Decision Sciences; Faculty of Medicine, University of Porto, Porto, Portugal; CINTESIS@RISE- Health Research Network, Faculty of Medicine, University of Porto, Porto, Portugal.
  • Zuberbier T; Institute of Allergology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Immunology and Allergology, Berlin, Germany; Department of Health R
  • Togias A; Division of Allergy, Immunology, and Transplantation (DAIT), National Institute of Allergy and Infectious Diseases, NIH, Bethesda, Maryland, US.
  • Samolinski B; Department of Prevention of Environmental Hazards, Allergology and Immunology, Medical University of Warsaw, Warsaw, Poland.
  • Bedbrook A; ARIA, Montpellier, France.
  • Czarlewski W; ARIA, Montpellier, France; Medical Consulting Czarlewski, Levallois, France.
  • Hofmann-Apitius M; Department of Bioinformatics, Fraunhofer Institute for Algorithms and Scientific Computing (SCAI), Bonn, Germany.
  • Litynska J; Evidence Prime, Kracow, Poland; Gynecological and Obstetrician Polyclinic, District Hospital, Bialystok, Poland.
  • Vieira RJ; MEDCIDS - Department of Community Medicine, Information and Health Decision Sciences; Faculty of Medicine, University of Porto, Porto, Portugal; CINTESIS@RISE- Health Research Network, Faculty of Medicine, University of Porto, Porto, Portugal.
  • Anto JM; ISGlobal, Barcelona Institute for Global Health, Barcelona, Spain; Universitat Pompeu Fabra (UPF), Barcelona, Spain; CIBER Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain.
  • Fonseca JA; MEDCIDS - Department of Community Medicine, Information and Health Decision Sciences; Faculty of Medicine, University of Porto, Porto, Portugal; CINTESIS@RISE- Health Research Network, Faculty of Medicine, University of Porto, Porto, Portugal.
  • Brozek J; Department of Health Research Methods, Evidence, and Impact & Department of Medicine, McMaster University, Hamilton, ON, Canada.
  • Bognanni A; Department of Health Research Methods, Evidence, and Impact & Department of Medicine, Evidence in Allergy group, McMaster University, Hamilton, ON, Canada.
  • Brussino L; Department of Medical Sciences, University of Torino, Torino, Italy; Allergy and Clinical Immunology Unit, Mauriziano Hospital, Torino, Italy.
  • Canonica GW; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy; IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.
  • Cherrez-Ojeda I; Universidad Espíritu Santo, Samborondón, Ecuador; Respiralab Research Group, Guayaquil, Guayas, Ecuador.
  • Cruz AA; Fundaçao ProAR, Federal University of Bahia and GARD/WHO Planning Group, Salvador, Bahia, Brazil.
  • Vecillas LL; Department of Allergy, Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain.
  • Dykewicz M; Section of Allergy and Immunology, Saint Louis University School of Medicine, Saint Louis, Missouri, USA.
  • Gemicioglu B; Department of Pulmonary Diseases, and Institute of Pulmonology & Tuberculosis, Istanbul University-Cerrahpasa, Cerrahpasa Faculty of Medicine, Istanbul, Turkey.
  • Giovannini M; Department of Health Sciences, University of Florence, Florence, Italy; Allergy Unit, Meyer Children's Hospital IRCCS, Florence, Italy.
  • Haahtela T; Skin and Allergy Hospital, Helsinki University Hospital, and University of Helsinki, Helsinki, Finland.
  • Jacobs M; Department of Bioinformatics, Fraunhofer Institute for Algorithms and Scientific Computing (SCAI), Bonn, Germany.
  • Jacomelli C; 'Respiriamo Insieme' association, Padova, Italy.
  • Klimek L; Department of Otolaryngology, Head and Neck Surgery, Universitätsmedizin Mainz, Mainz, Germany; Center for Rhinology and Allergology, Wiesbaden, Germany.
  • Kvedariene V; Institute of Clinical Medicine, Clinic of Chest Diseases and Allergology, Faculty of Medicine, Vilnius University, Vilnius, Lithuania; Institute of Biomedical Sciences, Department of Pathology, Faculty of Medicine, Vilnius University, Vilnius, Lithuania.
  • Larenas-Linnemann DE; Center of Excellence in Asthma and Allergy, Médica Sur Clinical Foundation and Hospital, México City, Mexico.
  • Louis G; Department of Public Health, University of Liège, Liège, Belgium.
  • Lourenço O; Faculty of Health Sciences and CICS - UBI, Health Sciences Research Centre, University of Beira Interior, Covilhã, Portugal.
  • Leemann L; Department of Political Science, University of Zürich, Zürich, Switerland.
  • Morais-Almeida M; Allergy Center, CUF Descobertas Hospital, Lisbon, Portugal.
  • Neves AL; Global Digital Health Unit, Department of Primary Care and Public Health, Imperial College, London, UK.
  • Nadeau KC; Department of Environmental Health, Harvard TH Chan School of Public Health and Department of Medicine, Division of Allergy and Inflammation, Beth Israel Deaconess Hospital, Boston, Massachusetts, USA.
  • Nowak A; Evidence Prime, Kracow, Poland; Gynecological and Obstetrician Polyclinic, District Hospital, Bialystok, Poland.
  • Palamarchuk Y; Finnish Meteorological Institute (FMI), Helsinki, Finland.
  • Palkonen S; EFA European Federation of Allergy and Airways Diseases Patients' Associations, Brussels, Belgium.
  • Papadopoulos NG; Allergy Department, 2nd Pediatric Clinic, University of Athens, Athens, Greece.
  • Parmelli E; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy; IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.
  • Pereira AM; MEDCIDS - Department of Community Medicine, Information and Health Decision Sciences; Faculty of Medicine, University of Porto, Porto, Portugal; PaCeIT - Patient Centered Innovation and Technologies, Center for Health Technology and Services Research (CINTESIS), Faculty of Medicine, University of Po
  • Pfaar O; Section of Rhinology and Allergy, Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Marburg, Philipps-Universität Marburg, Marburg, Germany.
  • Regateiro FS; Allergy and Clinical Immunology Unit, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal; Center for Innovative Biomedicine and Biotechnology (CIBB), Faculty of Medicine, University of Coimbra, Coimbra, Portugal; Institute of Immunology, Faculty of Medicine, University of Coimbra, Coimb
  • Savouré M; Université de Rennes, Inserm, EHESP, Irset (Institut de recherche en santé, environnement et travail) - UMR_S 1085, Rennes, France.
  • Taborda-Barata L; Department of Immunoallergology, Cova da Beira University Hospital Centre, Covilhã, Portugal; UBIAir - Clinical & Experimental Lung Centre and CICS-UBI Health Sciences Research Centre, University of Beira Interior, Covilhã, Portugal.
  • Toppila-Salmi SK; Department of Allergy, Skin and Allergy Hospital, Inflammation Center, Helsinki University Hospital and University of Helsinki, Helsinki, Finland; Department of Otorhinolaryngology, University of Eastern Finland and the North Savo wellbeing services county, Kuopio, Finland.
  • Torres MJ; Allergy Unit, Málaga Regional University Hospital of Málaga, Malaga University, ARADyAL, Malaga, Spain.
  • Valiulis A; Clinic of Children's Diseases, Institute of Clinical Medicine, Medical Faculty of Vilnius University, Vilnius, Lithuania; Clinic of Asthma, Allergy, and Chronic Lung Diseases, Vilnius, Lithuania.
  • Ventura MT; Allergy and Clinical Immunology, University of Bari Medical School, Bari, Italy; Institute of Sciences of Food Production, National Research Council (ISPA-CNR), Bari, Italy.
  • Williams S; International Primary Care Respiratory Group IPCRG, Edinburgh, Scotland.
J Allergy Clin Immunol Pract ; 2024 Jul 04.
Article en En | MEDLINE | ID: mdl-38971567
ABSTRACT
The traditional healthcare model is focused on diseases (medicine and natural science) and does not acknowledge patients' resources and abilities to be experts in their own life based on their lived experiences. Improving healthcare safety, quality and coordination, as well as quality of life, are important aims in the care of patients with chronic conditions. Person-centred care needs to ensure that people's values and preferences guide clinical decisions. This paper reviews current knowledge to develop (i) digital care pathways for rhinitis and asthma multimorbidity and (ii) digitally-enabled person-centred care (1). It combines all relevant research evidence, including the so-called real-world evidence, with the ultimate goal to develop digitally-enabled, patient-centred care. The paper includes (i) Allergic Rhinitis and its Impact on Asthma (ARIA), a two-decade journey, (ii) Grading of Recommendations, Assessment, Development and Evaluation (GRADE), the evidence-based model of guidelines in airway diseases, (iii) mHealth impact on airway diseases, (iv) from guidelines to digital care pathways, (v) embedding Planetary Health, (vi) novel classification of rhinitis and asthma, (vi) embedding real-life data with population-based studies, (vii) the ARIA-EAACI strategy for the management of airway diseases using digital biomarkers, (viii) Artificial Intelligence, (ix) the development of digitally-enabled ARIA Person-Centred Care and (x) the political agenda. The ultimate goal is to propose ARIA 2024 guidelines centred around the patient in order to make them more applicable and sustainable.
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: J Allergy Clin Immunol Pract Año: 2024 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: J Allergy Clin Immunol Pract Año: 2024 Tipo del documento: Article